[MARKET ANALYSIS] Global equites under pressure amid rising bond yields and energy prices, with two supertankers reportedly hit in Hormuz

European bourses are underwater on Tuesday, Euro Stoxx 50 (-0.3%), as the continued rise in global bond yields weigh on equities. The upside in energy prices isn't helping either, with the latest that two supertankers were hit in the Strait of Hormuz. These confluence of factors (rising yields and energy prices) have constantly been seen throughout the Iran war, which has resulted in European underperformance. Sectors have a negative bias. Energy, unsurprisingly, tops the sector pile. Optimised Personal Care and Chemicals round out the sector leaders. To the downside is Travel & Leisure, with Financial Services and Basic Resources completing the sector laggards. Plenty of pharmaceutical stories this morning. Starting with AstraZeneca (-1.4%): 1) its Tagrisso+Orpathys demonstrated highly clinically meaningful improvement in lung cancer patients, 2) acquired worldwide rights to develop and commercialise Zegfrovy, and 3) Enhertu has been approved in the EU for 1L HER2-positive metastatic breast cancer. For Novartis (+4.2%), the Co. announced that its remibrutinib significantly reduces relapse rates and shows favourable safety profile in Phase III RMS trials. Other key movers include: UK homebuilders, as Nationwide House Price Index printed at 1.6% Y/Y (exp. 2.1%); Air Liquide (+2.6%), FT reports of Elliott building a stake in the Co.; Partners Group (-7.5%), H1 revenue missed and its CEO steps down into an investment role; Reckitt Benckiser (+4.4%), upgraded at JPMorgan, and its Mead Johnson unit won a federal case regarding its baby formula. US equity futures are also underpressure this morning, in line with its European peers. Focus will be on Dell and Palo Alto earnings after-hours.